On November 27, 2024, Richard Dilorio, the CEO of InfuSystems Holdings Inc (INFU, Financial), sold 40,000 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now owns 456,659 shares of the company.
InfuSystems Holdings Inc (INFU) is a leading provider of infusion pumps and related services for the healthcare industry. The company offers a comprehensive suite of products and services that support the delivery of infusion therapy to patients in various settings, including hospitals, clinics, and home care.
The insider transaction history for InfuSystems Holdings Inc shows that there have been seven insider buys in total over the past year, while there has been one insider sell during the same period. Over the past year, Richard Dilorio has sold 40,000 shares in total and purchased zero shares.
On the day of the recent sale, shares of InfuSystems Holdings Inc were trading at $9.11 each, giving the stock a market cap of $188.395 million. The company's price-earnings ratio stands at 140.63, which is higher than the industry median of 29.32 and also higher than the company’s historical median price-earnings ratio.
With a price of $9.11 and a GF Value of $10.88, InfuSystems Holdings Inc has a price-to-GF-Value ratio of 0.84, indicating that the stock is modestly undervalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
